I’m an internationally recognized consultant and author with over 30 years of experience in the field of strategy development and execution, business model design, and market analysis. My work across the entire healthcare spectrum gives me a unique perspective on the challenges
What Trump’s Executive Order Could Mean For Healthcare
Trump's EO is ambitious in scope, and highlights actions taken during his first administration that were aimed at reducing the cost of prescription drugs.
America’s Dependence On Foreign Medicine Is A Risk We Can’t Afford—Tariffs Are Forcing A Reckoning
The tariffs, touted as a remedy to global vulnerabilities, have thrust the long-ignored flaws of the U.S. drug supply chain into the spotlight.
Trump’s Executive Order Demands Accountability In Hospital Price Transparency
Trump’s action reflects a step toward enforcing long-ignored regulations, ensuring patients have access to pricing information to make informed healthcare decisions.
The High Cost Of Cutting Staff: Pharma Layoffs And The Future Of Innovation
Most organizations can afford a 10% efficiency cut, providing immediate financial relief, but how these cuts are done often creates new inefficiencies elsewhere.
Utilization Management Is Broken–Fixing It Requires A New Business Model
If insurers want to be seen as partners rather than adversaries, they need to need to rethink core elements of their business model.